✦ LIBER ✦

Hepatitis-B-vaccinatie: wèl of geen booster?

✍ Scribed by P. A van Hasselt

Publisher: Prelum Uitgevers
Year: 2006
Weight: 45 KB
Volume: 44
Category: Article
ISSN: 0168-7670
DOI: 10.1007/bf03058747

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Immune responses to late booster doses o

Immune responses to late booster doses of hepatitis B vaccine

✍ Dr. Wolfgang Jilg; Marion Schmidt; Friedrich Deinhardt 📂 Article 📅 1985 🏛 John Wiley and Sons 🌐 English ⚖ 295 KB 👁 1 views

Nineteen healthy young adults were vaccinated with plasma-derived hepatitis B vaccine at months 0, 1, and 12, and their immune responses were compared to those of a similar group of 20 vaccinees immunized at months 0, 1, and 6. Late booster injections at 12 months produced nearly fivefold higher geo

Determination of immune memory to hepati

Determination of immune memory to hepatitis B vaccination through early booster response in college students

✍ Chyi-Feng Jan; Kuo-Chin Huang; Yin-Chu Chien; Donald E. Greydanus; H. Dele Davie 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 170 KB 👁 1 views

Immunogenicity of a recombinant pre-S2-c

Immunogenicity of a recombinant pre-S2-containing hepatitis B vaccine versus plasma-derived vaccine administered as a booster

✍ B. Bucher; P. Francioli; B. Geudelin; B. Fritzell; D. Lavanchy; P. C. Frei 📂 Article 📅 1994 🏛 Springer 🌐 English ⚖ 660 KB

Hepatitis B vaccination in patients infe

Hepatitis B vaccination in patients infected with Schistosoma mansoni: duration of immunity and immunogenicity of a low dose intradermal booster

✍ S. Bassily; K.C. Hyams; N. El-Ghorab; N. El-Masry 📂 Article 📅 1990 🏛 Elsevier Science 🌐 English ⚖ 192 KB

Characterization of a human monoclonal a

Characterization of a human monoclonal antibody obtained after immunization with plasma vaccine and a booster with recombinant-DNA hepatitis B vaccine

✍ R.A. Heijtink; J. Kruining; P. van Bergen; S. de Rave; J. van Hattum; M. Schutte 📂 Article 📅 2002 🏛 John Wiley and Sons 🌐 English ⚖ 204 KB

A human monoclonal antibody type IgG4, designated 1Ff4, was obtained by Epstein Barr virus transformation of peripheral blood lymphocytes from a hepatitis B vaccinee (HB-VAX: plasmaderived vaccine) after one boost of yeast recombinant DNA derived vaccine (Engerix-B). 1Ff4 binds preferentially to HBs

Response to a booster dose 18 months aft

Response to a booster dose 18 months after a low anti-HBs response (10–99 IU/l) to three doses of intradermally or intramuscularly administered recombinant hepatitis B vaccine

✍ J. Struve; Ola Weiland; Marianne Fosgren; B. Aronsson; B. Frenning 📂 Article 📅 1995 🏛 Springer-Verlag 🌐 English ⚖ 686 KB